SRI LANKA - Novus International, Inc. has hosted an informational enzyme forum to formally introduce its next generation phytase enzyme, CIBENZA PHYTAVERSE, to the South Asia market in Negomba, Sri Lanka from 27 to 29 August.
Stakeholders, leading experts and academics participated in a series of discussions, interactive sessions and workshops that highlighted the use of enzymes as essential tools for improving animal nutrition and reducing feed costs.
The summit had a strong participation from all attendees who shared their experiences with the CIBENZA® family of enzyme products.
CIBENZA PHYTAVERSE® offers significant advantages over other phytase enzymes available on the market. The product’s unique performance characteristics include: high in vivo activity under gastric conditions for sustained performance; improved activity at low substrate concentrations to maximise phytate hydrolysis; high gastric stability for activity throughout the upper gastrointestinal tract; high intrinsic thermotolerance and pelleting stability; as well as improved bioavailability due to eliminating the need for thermo protective coatings. These characteristics support nutrient utilisation and can increase producers’ return on investment.
“Our customers are interested in the economic benefits of our products. It is crucial that feed additives are backed up by independent studies and have a proven ROI,” said Dr Vaibhav Nagpal, director of South Asia and South East Asia Pacific at Novus.
“We are confident that our solid and respected reputation in the industry, as well as the extensive research behind CIBENZA PHYTAVERSE, will offer producers in South Asia the knowledge and assurance to incorporate the product into their operations and see the exceptional benefits it offers.”
For more information on CIBENZA PHYTAVERSE and other cost-effective nutrition solutions offered by Novus, visit the company’s web site at www.novusint.com.ThePoultrySite News Desk